RNU1-45P

Across TCGA pan-cancer cohorts, RNU1-45P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU1-45P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU1-45P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-45P expression acts as an unfavorable survival marker.

LIHC and STAD are the cancer types where RNU1-45P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.126	0.786	<.001	63	view →
STAD	OS	Tertile	All	0.119	0.539	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU1-45P–LIHC (OS)

Open the LIHC breakdown →